Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -50.87% vs 2,123.08% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -487.88% vs 113.04% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -407.69% vs 115.29% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -4.35% vs 27.78% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Lexicon Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -50.87% vs 2,123.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 735.29% vs 750.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -487.88% vs 113.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 80.25% vs -28.32% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -407.69% vs 115.29% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 81.13% vs -28.48% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -4.35% vs 27.78% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -52.17% vs 17.95% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






